<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK32533" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK32533/" /><meta name="ncbi_pagename" content="HTRA1 Disorder - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>HTRA1 Disorder - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="HTRA1 Disorder" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/11/07" /><meta name="citation_author" content="Osamu Onodera" /><meta name="citation_author" content="Hiroaki Nozaki" /><meta name="citation_author" content="Toshio Fukutake" /><meta name="citation_pmid" content="20437615" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK32533/" /><meta name="citation_keywords" content="CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy)" /><meta name="citation_keywords" content="CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy)" /><meta name="citation_keywords" content="Classic CARASIL" /><meta name="citation_keywords" content="HTRA1 Cerebral Small Vessel Disease (HTRA1-CSVD)" /><meta name="citation_keywords" content="Serine protease HTRA1" /><meta name="citation_keywords" content="HTRA1" /><meta name="citation_keywords" content="HTRA1 Disorder" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="HTRA1 Disorder" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Osamu Onodera" /><meta name="DC.Contributor" content="Hiroaki Nozaki" /><meta name="DC.Contributor" content="Toshio Fukutake" /><meta name="DC.Date" content="2019/11/07" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK32533/" /><meta name="description" content="HTRA1 disorder is a phenotypic spectrum in which some individuals have few to no symptoms and others manifest with the more severe CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) phenotype. Those who have a heterozygous HTRA1 pathogenic variant may have mild neurologic findings (sometimes identified only on neuroimaging) or mild-to-moderate neurologic signs and symptoms of CARASIL. In this chapter, the term &quot;classic CARASIL&quot; refers to the more severe phenotype associated with biallelic pathogenic variants, and &quot;HTRA1 cerebral small vessel disease&quot; (HTRA1-CSVD) refers to the milder phenotype associated with a heterozygous HTRA1 pathogenic variant." /><meta name="og:title" content="HTRA1 Disorder" /><meta name="og:type" content="book" /><meta name="og:description" content="HTRA1 disorder is a phenotypic spectrum in which some individuals have few to no symptoms and others manifest with the more severe CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy) phenotype. Those who have a heterozygous HTRA1 pathogenic variant may have mild neurologic findings (sometimes identified only on neuroimaging) or mild-to-moderate neurologic signs and symptoms of CARASIL. In this chapter, the term &quot;classic CARASIL&quot; refers to the more severe phenotype associated with biallelic pathogenic variants, and &quot;HTRA1 cerebral small vessel disease&quot; (HTRA1-CSVD) refers to the milder phenotype associated with a heterozygous HTRA1 pathogenic variant." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK32533/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/carasil/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK32533/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE881C4CE0411951000000000096003C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK32533_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK32533_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hemochromatosis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hfg/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK32533_"><span class="title" itemprop="name"><i>HTRA1</i> Disorder</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: CARASIL (<i>C</i>erebral <i>A</i>utosomal <i>R</i>ecessive <i>A</i>rteriopathy with <i>S</i>ubcortical <i>I</i>nfarcts and <i>L</i>eukoencephalopathy)</div><p class="contrib-group"><span itemprop="author">Osamu Onodera</span>, MD, PhD, <span itemprop="author">Hiroaki Nozaki</span>, MD, PhD, and <span itemprop="author">Toshio Fukutake</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK32533_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK32533_ai__"><div class="contrib half_rhythm"><span itemprop="author">Osamu Onodera</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Brain Research Institute<br />Niigata University<br />Niigata, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-atagiin.irb@aredono" class="oemail">pj.ca.u-atagiin.irb@aredono</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hiroaki Nozaki</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Brain Research Institute<br />Niigata University<br />Niigata, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-atagiin.irb@kazon" class="oemail">pj.ca.u-atagiin.irb@kazon</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Toshio Fukutake</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Kameda Medical Center<br />Kamogawa, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ademak@oihsot.ekatukuf" class="oemail">pj.ademak@oihsot.ekatukuf</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">April 27, 2010</span>; Last Update: <span itemprop="dateModified">November 7, 2019</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="carasil.Summary" itemprop="description"><h2 id="_carasil_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>HTRA1</i> disorder is a phenotypic spectrum in which some individuals have few to no symptoms and others manifest with the more severe CARASIL (<i>c</i>erebral <i>a</i>utosomal <i>r</i>ecessive <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Those who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may have mild neurologic findings (sometimes identified only on neuroimaging) or mild-to-moderate neurologic signs and symptoms of CARASIL. In this chapter, the term "classic CARASIL" refers to the more severe phenotype associated with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants, and "<i>HTRA1</i> cerebral small vessel disease" (<i>HTRA1</i>-CSVD) refers to the milder phenotype associated with a heterozygous <i>HTRA1</i> pathogenic variant.</p><ul><li class="half_rhythm"><div>Classic CARASIL is characterized by early-onset changes in the deep white matter of the brain observed on MRI, and associated neurologic findings. The most frequent initial symptom is gait disturbance from spasticity beginning between ages 20 and 40 years. Forty-four percent of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have stroke-like episodes before age 40 years. Mood changes (apathy and irritability), pseudobulbar palsy, and cognitive dysfunction begin between ages 20 and 50 years. The disease progresses slowly following the onset of neurologic symptoms. Scalp alopecia and acute mid- to lower-back pain (lumbago) before age 30 years are characteristic.</div></li><li class="half_rhythm"><div>The most frequent initial symptom in individuals with <i>HTRA1</i>-CSVD is slowly progressive gait disturbance after age 40 years, which may be followed by the development of mood changes and cognitive dysfunction. A majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a stroke-like episode after age 40 years. Spondylosis and alopecia are seen in a minority of individuals with <i>HTRA1</i>-CSVD.</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>HTRA1</i> disorder is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of either a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in <i>HTRA1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Consideration of anti-platelet therapy and anti-hypertensive therapy for those with cerebral microbleeds; physical therapy, walking aids, and home adaptations for those with gait disturbance; consideration of medication (baclofen or tizanidine) for spasticity; wig or hairpiece for those with alopecia; standard treatment for spinal spondylosis and mood disorder; supportive care including emotional support and counseling for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and their families.</p><p><i>Surveillance:</i> Follow-up intervals are based on the severity and type of symptoms and the needs of the individuals and their caregivers.</p><p><i>Agents/circumstances to avoid</i>: Smoking and a high-salt diet, which may hasten the progression of arteriosclerosis.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>HTRA1</i> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants (i.e., the classic CARASIL <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. <i>HTRA1</i> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><ul><li class="half_rhythm"><div><i>Autosomal recessive inheritance</i>. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of inheriting both <i>HTRA1</i> pathogenic variants and being affected, a 50% chance of inheriting one <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, and a 25% chance of inheriting neither pathogenic variant and not being at risk for <i>HTRA1</i> disorder.</div></li><li class="half_rhythm"><div><i>Autosomal dominant inheritance</i>. Each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 50% risk of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from their affected parent.</div></li></ul><p>Once the <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for <i>HTRA1</i> disorder are possible.</p></div></div><div id="carasil.GeneReview_Scope"><h2 id="_carasil_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="carasil.Td" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.Td/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.Td_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_carasil.Td_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>HTRA1</i> Disorder: Included Phenotypes</th></tr></thead><tbody><tr><td headers="hd_h_carasil.Td_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Classic CARASIL</div></li><li class="half_rhythm"><div><i>HTRA1</i> cerebral small vessel disease (<i>HTRA1</i>-CSVD)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonym s and outdated names see <a href="#carasil.Nomenclature">Nomenclature</a>.</p></div></dd></dl></div></div></div></div><div id="carasil.Diagnosis"><h2 id="_carasil_Diagnosis_">Diagnosis</h2><p>Clinical diagnostic criteria for <i>HTRA1</i> disorder, including the classic CARASIL <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> ("classic CARASIL"), have not been published.</p><div id="carasil.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>HTRA1</i> disorder <b>should be suspected</b> in individuals with the following clinical, neuroimaging, and family history findings.</p><p><b>Clinical features.</b> Individuals <b>presenting before age 55 years</b> with the following:</p><ul><li class="half_rhythm"><div>Slowly progressive dementia</div></li><li class="half_rhythm"><div>Mood changes, such as apathy and irritability</div></li><li class="half_rhythm"><div>Slowly progressive gait disturbance with spasticity in the lower extremities [<a class="bk_pop" href="#carasil.REF.fukutake.1995.69">Fukutake &#x00026; Hirayama 1995</a>, <a class="bk_pop" href="#carasil.REF.fukutake.2011.85">Fukutake 2011</a>, <a class="bk_pop" href="#carasil.REF.nozaki.2014.3447">Nozaki et al 2014</a>]</div></li></ul><p>Note: Those with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<i>HTRA1</i> cerebral small vessel disease) may present with these features after age 55 years.</p><p>Additional young adult-onset findings in those with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HTRA1</i> (classic CARASIL):</p><ul><li class="half_rhythm"><div class="half_rhythm">Spondylosis deformans. Acute mid- to lower-back pain (lumbago) associated with spondylosis and disk degeneration with osteophyte formation in the lumbar spine</div></li><li class="half_rhythm"><div class="half_rhythm">Alopecia. Typically seen before age 30 years</div><div class="half_rhythm">Note: Alopecia is variable; <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>HTRA1</i> pathogenic variants without alopecia have been reported [<a class="bk_pop" href="#carasil.REF.nishimoto.2011.1353">Nishimoto et al 2011</a>, <a class="bk_pop" href="#carasil.REF.nozaki.2014.3447">Nozaki et al 2014</a>].</div></li></ul><p><b>Neuroimaging.</b> Extended white matter lesions and external capsule lesions:</p><ul><li class="half_rhythm"><div>Early-onset leukoaraiosis (changes in deep white matter in the brain, observed on MRI or CT). Leukoaraiosis may precede neurologic symptoms [<a class="bk_pop" href="#carasil.REF.fukutake.2011.85">Fukutake 2011</a>, <a class="bk_pop" href="#carasil.REF.nozaki.2015.459">Nozaki et al 2015</a>].</div></li><li class="half_rhythm"><div>Brain MRI resembling that of <a href="/books/n/gene/cadasil/">CADASIL</a> (<i>c</i>erebral <i>a</i>utosomal <i>d</i>ominant <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy). Findings in symptomatic individuals may include the following [<a class="bk_pop" href="#carasil.REF.fukutake.2011.85">Fukutake 2011</a>, <a class="bk_pop" href="#carasil.REF.nozaki.2015.459">Nozaki et al 2015</a>]:</div><ul><li class="half_rhythm"><div class="half_rhythm">Symmetrically distributed white matter hyperintensities located in the periventricular and deep white matter</div><div class="half_rhythm">Note: White matter changes may precede the onset of neurologic symptoms, including gait disturbance, mood change, and cognitive decline.</div></li><li class="half_rhythm"><div class="half_rhythm">T<sub>2</sub>-weighted signal abnormalities in the white matter of the anterior part of the temporal lobe, cerebellum, brain stem, and middle cerebellar peduncle (arc sign), and in the external capsule</div></li><li class="half_rhythm"><div class="half_rhythm">Relative preservation of U-fibers</div></li><li class="half_rhythm"><div class="half_rhythm">Lacunar infarcts (linearly arranged groups of rounded and circumscribed lesions with signal intensity identical to that of cerebrospinal fluid) in the basal ganglia and subcortical white matter</div></li><li class="half_rhythm"><div class="half_rhythm">Microbleeds in the cerebral cortex, basal ganglia, brain stem, and cerebellum</div><div class="half_rhythm">Note: It is not clear if the white matter changes in the anterior temporal poles and external capsule, which are characteristic signs in CADASIL, are also observed in early stages of CARASIL.</div></li></ul></li></ul><p><b>Family history</b> consistent with:</p><ul><li class="half_rhythm"><div>Autosomal recessive inheritance in those with classic CARASIL</div></li><li class="half_rhythm"><div>Autosomal dominant inheritance for those with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<i>HTRA1</i>-CSVD)</div></li></ul><p>Note: Absence of a known family history of <i>HTRA1</i> disorder does not preclude the diagnosis.</p></div><div id="carasil.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>HTRA1</i> disorder <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of either a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HTRA1</i> on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK32533/table/carasil.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figcarasilTmoleculargenetictestingused" rid-ob="figobcarasilTmoleculargenetictestingused">Table 1</a>).</p><p>Molecular genetic testing approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing or <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of <i>HTRA1</i> disorder is broad, individuals with the distinctive findings described in <a href="#carasil.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#carasil.Option_1">Option 1</a>), whereas those in whom the diagnosis of CARASIL has not been considered are more likely to be diagnosed using genomic testing (see <a href="#carasil.Option_2">Option 2</a>).</p><div id="carasil.Option_1"><h4>Option 1</h4><p>When the phenotypic and imaging findings suggest the diagnosis of classic CARASIL, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>HTRA1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Given the mechanism of disease causation (see <a href="#carasil.Molecular_Genetics">Molecular Genetics</a>), it is unclear whether exon or whole-gene deletions/duplications cause this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A cerebral small vessel disease</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>HTRA1</i> and other genes of interest (see <a href="#carasil.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="carasil.Option_2"><h4>Option 2</h4><p>When the diagnosis of CARASIL or <i>HTRA1</i> disorder is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="carasil.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>HTRA1</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>HTRA1</i></td><td headers="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Estimated &#x0003e;95%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<br /><a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>5</sup></td><td headers="hd_h_carasil.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="carasil.TF.1.1"><p class="no_margin">See <a href="/books/NBK32533/#carasil.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="carasil.TF.1.2"><p class="no_margin">See <a href="#carasil.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="carasil.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="carasil.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#carasil.REF.hara.2009.1729">Hara et al [2009]</a></p></div></dd><dt>5. </dt><dd><div id="carasil.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="carasil.TF.1.6"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div></div><div id="carasil.Clinical_Characteristics"><h2 id="_carasil_Clinical_Characteristics_">Clinical Characteristics</h2><div id="carasil.Clinical_Description"><h3>Clinical Description</h3><p><i>HTRA1</i> disorder is a phenotypic spectrum in which some individuals have few to no symptoms and others manifest with the more severe classic CARASIL (<i>c</i>erebral <i>a</i>utosomal <i>r</i>ecessive <i>a</i>rteriopathy with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy) <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Those who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may have mild neurologic findings (sometimes identified only on neuroimaging) or mild-to-moderate neurologic signs and symptoms of CARASIL [<a class="bk_pop" href="#carasil.REF.verdura.2015.2347">Verdura et al 2015</a>, <a class="bk_pop" href="#carasil.REF.nozaki.2016.1964">Nozaki et al 2016</a>].</p><div id="carasil.HATR1_Disorder_Caused_by_Biallel"><h4><i>HATR1</i> Disorder Caused by Biallelic <i>HATR1</i> Pathogenic Variants (Classic CARASIL)</h4><p><b>Neurologic symptoms</b> begin between ages 20 and 50 years.</p><ul><li class="half_rhythm"><div>The most frequent initial symptom is slowly progressive gait disturbance from spasticity and pyramidal signs in the lower extremities beginning between ages 20 and 40 years.</div></li><li class="half_rhythm"><div>Mood change (depression and irritability) and cognitive dysfunction begin between ages 20 and 50 years.</div></li><li class="half_rhythm"><div>Pseudobulbar palsy also begins between ages 30 and 50 years.</div></li><li class="half_rhythm"><div>Forty-four percent of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have a stroke-like episode (e.g., hemiparesis or hemisensory impairment) before age 40 years.</div></li><li class="half_rhythm"><div>The disease progresses slowly following the onset of neurologic symptoms. In the advanced stage, emotional incontinence, abulia, and akinetic mutism develop.</div></li></ul><p><b>Spondylosis</b> (disk degeneration with osteophyte formation), which typically follows acute lower- and mid-back pain (lumbago), results in lower-limb pain beginning between ages ten and 30 years. Severe spondylosis deformans with osteoporosis in the cervical and lumbar spine [<a class="bk_pop" href="#carasil.REF.nozaki.2015.459">Nozaki et al 2015</a>] and deformity and formation of osseous specula in the knee joints [<a class="bk_pop" href="#carasil.REF.yanagawa.2002.817">Yanagawa et al 2002</a>] may be appreciated on plain radiographs.</p><p><b>Alopecia</b> is frequently (not always) seen before age 30 years.</p><ul><li class="half_rhythm"><div>Scalp alopecia is diffuse, not confined to the frontal or parietal regions.</div></li><li class="half_rhythm"><div>There is no obvious body hair loss.</div></li></ul><p><b>Pathology.</b> From the autopsy findings, arteriosclerosis associated with intimal thickening and dense collagen fibers, loss of vascular smooth muscle cells, and hyaline degeneration of the media have been observed in cerebral small arteries. These pathologic findings resemble those observed in persons with non-hereditary ischemic cerebral small vessel disease [<a class="bk_pop" href="#carasil.REF.okeda.2004.21">Okeda et al 2004</a>, <a class="bk_pop" href="#carasil.REF.oide.2008.132">Oide et al 2008</a>, <a class="bk_pop" href="#carasil.REF.ito.2016">Ito et al 2016</a>]. However, multilayering and splitting of elastic laminae may be specific for CARASIL. These changes are predominant in cerebral small arteries; therefore, skin biopsy is not useful for diagnosis.</p><p>Note: Granular osmiophilic material within the vascular media close to smooth muscle cells, a pathologic hallmark for CADASIL, is never observed in CARASIL.</p></div><div id="carasil.HTRA1_Disorder_Caused_by_a_Heter"><h4><i>HTRA1</i> Disorder Caused by a Heterozygous Pathogenic Variant (<i>HTRA1</i> Cerebral Small Vessel Disease)</h4><p><b>Neurologic symptoms</b> typically begin after age 40 years [<a class="bk_pop" href="#carasil.REF.nozaki.2016.1964">Nozaki et al 2016</a>] and include the following:</p><ul><li class="half_rhythm"><div>Slowly progressive gait disturbance (the most frequent initial symptom)</div></li><li class="half_rhythm"><div>Mood change (depression and irritability) and cognitive dysfunction</div></li><li class="half_rhythm"><div>A stroke-like episode (e.g., hemiparesis or hemisensory impairment) in 63% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Slow progression of the disease following the onset of neurologic symptoms</div></li></ul><p><b>Spondylosis and alopecia</b> are rarer findings.</p><ul><li class="half_rhythm"><div>Spondylosis deformans is seen in about 36% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Alopecia is seen in about 20% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul><p><b>Pathology.</b> Small vessels in the central nervous system have shown intimal proliferation, splitting of the internal elastic lamina, and degeneration of smooth muscle cells in the tunica media. The features resemble those of individuals with classic CARASIL [<a class="bk_pop" href="#carasil.REF.nozaki.2016.1964">Nozaki et al 2016</a>, <a class="bk_pop" href="#carasil.REF.ito.2018">Ito et al 2018</a>].</p></div></div><div id="carasil.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No strong <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> for <i>HTRA1</i> have been identified in classic CARASIL [<a class="bk_pop" href="#carasil.REF.hara.2009.1729">Hara et al 2009</a>, <a class="bk_pop" href="#carasil.REF.favaretto.2019.108">Favaretto et al 2019</a>].</p><p>Those who have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant that either leads to defective trimerization or is located in the LD or L3 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> may have a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> than those who have a heterozygous <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant [<a class="bk_pop" href="#carasil.REF.nozaki.2016.1964">Nozaki et al 2016</a>, <a class="bk_pop" href="#carasil.REF.uemura.2019.693">Uemura et al 2019</a>].</p></div><div id="carasil.Nomenclature"><h3>Nomenclature</h3><p>Other names for <i>HTRA1</i> disorder include the following:</p><ul><li class="half_rhythm"><div>CARASIL, for those who have <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>HTRA1</i> pathogenic variants</div></li><li class="half_rhythm"><div>Familial young adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension</div></li><li class="half_rhythm"><div>Nemoto disease</div></li><li class="half_rhythm"><div>Maeda syndrome</div></li><li class="half_rhythm"><div>CADASIL2 (<i>c</i>erebral <i>a</i>rteriopathy, <i>a</i>utosomal <i>d</i>ominant, with <i>s</i>ubcortical <i>i</i>nfarcts and <i>l</i>eukoencephalopathy, type 2; OMIM <a href="https://omim.org/entry/616779" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">616779</a>)</div></li></ul></div><div id="carasil.Prevalence"><h3>Prevalence</h3><p><i>HTRA1</i> disorder has been reported in individuals from Asia, Europe, and North America. However, no founder haplotype has been identified; thus, the authors suspect that the disease will be found more widely.</p></div></div><div id="carasil.Genetically_Related_Allelic_Diso"><h2 id="_carasil_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>HTRA1</i>.</p></div><div id="carasil.Differential_Diagnosis"><h2 id="_carasil_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Other inherited disorders</b> that cause leukoaraiosis in adulthood are summarized in <a class="figpopup" href="/books/NBK32533/table/carasil.T.inherited_disorders_with_adult/?report=objectonly" target="object" rid-figpopup="figcarasilTinheriteddisorderswithadult" rid-ob="figobcarasilTinheriteddisorderswithadult">Table 2</a>. They can be distinguished from <i>HTRA1</i> disorder by clinical signs, MRI findings, and appropriate laboratory investigations.</p><p>Note: Classic CARASIL should be considered in any young person who has alopecia in conjunction with multiple white matter lesions on MRI.</p><div id="carasil.T.inherited_disorders_with_adult" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Inherited Disorders with Adult-Onset Leukoaraiosis to Consider in the Differential Diagnosis of <i>HTRA1</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.T.inherited_disorders_with_adult/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.T.inherited_disorders_with_adult_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Description</th></tr></thead><tbody><tr><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL4A1</i>, <i>COL4A2</i></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL4A1-</i> &#x00026; <i>COL4A2</i>-related small vessel disease (see <a href="/books/n/gene/col4a1-dis/"><i>COL4A1</i>-Related Disorders</a>)</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Intracranial aneurysm</div></li><li class="half_rhythm"><div>Renal abnormalities (hematuria, cystic kidney)</div></li><li class="half_rhythm"><div>Muscle cramps</div></li><li class="half_rhythm"><div>Retinal arteriolar tortuosity (retinal hemorrhages)</div></li></ul>
</td></tr><tr><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CTSA</i></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CARASAL</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Therapy-resistant hypertension&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GLA</i></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fabry/">Fabry disease</a></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Periodic severe pain in extremities</div></li><li class="half_rhythm"><div>Angiokeratoma</div></li><li class="half_rhythm"><div>Renal insufficiency</div></li><li class="half_rhythm"><div>Hypohidrosis</div></li><li class="half_rhythm"><div>Left ventricular hypertrophy</div></li><li class="half_rhythm"><div>Corneal opacities</div></li></ul>
</td></tr><tr><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ITM2B</i></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Familial British dementia (OMIM <a href="https://omim.org/entry/176500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">176500</a>)</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ataxia, spasticity</td></tr><tr><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH3</i></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cadasil/">CADASIL</a>&#x000a0;<sup>2,</sup>&#x000a0;<sup>3</sup></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Isolated T<sub>2</sub>-weighted hyperintensities involving temporal poles on brain MRI</td></tr><tr><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TREX1</i></td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">HERNS (OMIM <a href="https://omim.org/entry/192315" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">192315</a>)</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_carasil.T.inherited_disorders_with_adult_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Contrast-enhancing lesion mimicking tumor on brain MRI</div></li><li class="half_rhythm"><div>Retinal artery abnormalities (macular capillary dropout, tortuous telangiectasia)</div></li><li class="half_rhythm"><div>Progressive visual loss</div></li><li class="half_rhythm"><div>Raynaud phenomenon</div></li><li class="half_rhythm"><div>Migraine</div></li><li class="half_rhythm"><div>Proteinuria &#x00026; hematuria</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; CARASAL = cathepsin A-related arteriopathy with strokes and leukoencephalopathy; HERNS = hereditary endotheliopathy with retinopathy, nephropathy, and stroke; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="carasil.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#carasil.REF.bugiani.2016.1777">Bugiani et al [2016]</a></p></div></dd><dt>2. </dt><dd><div id="carasil.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#carasil.REF.chabriat.2009.643">Chabriat et al [2009]</a></p></div></dd><dt>3. </dt><dd><div id="carasil.TF.2.3"><p class="no_margin">Recommended laboratory investigations: skin biopsy evaluation for NOTCH3 protein expression and electron microscopy for granular osmophilic material</p></div></dd></dl></div></div></div><p><b>Other.</b> The clinical characteristics and MRI abnormalities in the following conditions may also resemble those of CARASIL:</p><ul><li class="half_rhythm"><div>Small vessel diseases (e.g., <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> SVD, Portuguese-French type [<a class="bk_pop" href="#carasil.REF.verreault.2006.353">Verreault et al [2006]</a>)</div></li><li class="half_rhythm"><div>Swedish hereditary multi-infarct dementia [<a class="bk_pop" href="#carasil.REF.low.2007.357">Low et al 2007</a>]</div></li><li class="half_rhythm"><div>Sporadic small vessel diseases including Binswanger disease and primary angiitis of the nervous system (Binswanger disease can be distinguished from CARASIL by the presence of hypertension.)</div></li></ul></div><div id="carasil.Management"><h2 id="_carasil_Management_">Management</h2><p>Consensus clinical management guidelines for <i>HTRA1</i> disorder, including classic CARASIL, have not been published.</p><div id="carasil.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>HTRA1</i> disorder, the evaluations summarized in Table (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="carasil.T.recommended_evaluations_follow" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>HTRA1</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.T.recommended_evaluations_follow/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.T.recommended_evaluations_follow_lrgtbl__"><table><thead><tr><th id="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl scales to evaluate severity of gait disturbance &#x00026; pseudobulbar palsy</td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">T<sub>2</sub>*-weighted gradient echo imaging</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for cerebral microbleeds</td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Psychiatric</b></td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neuropsychiatric evaluation</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To screen for anxiety, mood disturbance, &#x00026; cognitive dysfunction</td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal</b></td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider feeding &#x00026;/or swallowing study.</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If there is concern for pseudobulbar palsy</td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Skeletal</b></td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider MRI of spine.</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for degenerative changes in lumbar or cervical spine</td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dermatologic</b></td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for scalp alopecia</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr><tr><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Family supports/resources</td><td headers="hd_h_carasil.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="carasil.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Supportive care in the form of practical help, emotional support, and counseling are appropriate for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and their families.</p><div id="carasil.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with <i>HTRA1</i> Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.T.treatment_of_manifestations_in_lrgtbl__"><table><thead><tr><th id="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cerebral microbleeds</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anti-platelet therapy &#x00026; anti-hypertension therapy may be considered.</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">There is no evidence for their effectiveness.</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gait disturbance</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical therapy to ameliorate coordination difficulties, especially w/walking</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Crutches (less often canes) &#x00026; walkers</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To prevent falls</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Home adaptations incl grab bars for bathtub or shower chairs, raised toilet seats, &#x00026; ramps to accommodate motorized chairs, as needed</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Medication (e.g., baclofen, tizanidine)</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">May be considered for those w/spasticity</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Mood disorder</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per psychiatrist</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Personality changes may necessitate antipsychotic medication.</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Pseudobulbar palsy</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Speech/language therapy</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Communication devices such as writing pads &#x00026; computer-based devices may also be of benefit.</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Video esophagrams can identify consistency of food least likely to trigger aspiration.</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Weighted eating utensils &#x00026; dressing hooks help maintain a sense of independence.</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Spinal spondylosis</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment per orthopedist</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">For those w/neurologic deficits due to spinal compression</td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Alopecia</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Wig or hairpiece</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Family/Community</b></td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Ensure appropriate social work involvement to connect families w/local resources, respite, &#x00026; support.</div></li><li class="half_rhythm"><div>Coordinate care to manage multiple subspecialty appointments, equipment, medications, &#x00026; supplies.</div></li></ul>
</td><td headers="hd_h_carasil.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ongoing assessment for need of home nursing</td></tr></tbody></table></div></div></div><div id="carasil.Surveillance"><h3>Surveillance</h3><p>The interval at which a person with <i>HTRA1</i> disorder is followed depends on the severity and type of symptoms and the needs of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and caregivers.</p></div><div id="carasil.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Smoking and a high-salt diet, which may hasten the progression of arteriosclerosis, should be avoided.</p></div><div id="carasil.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It has been speculated that hypertension or smoking may influence the age of onset and frequency of stroke episodes in individuals with <i>HTRA1</i> disorder; smoking may result in earlier disease onset [<a class="bk_pop" href="#carasil.REF.singhal.2004.2031">Singhal et al 2004</a>], and smoking or hypertension may increase the frequency of stroke episodes in individuals with the classic CADASIL <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> [<a class="bk_pop" href="#carasil.REF.adibsamii.2010.630">Adib-Samii et al 2010</a>]. Therefore, it is appropriate to test the older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> for presence of the <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family in order to identify early in adulthood (ideally at age &#x02265;18 years) those who would benefit from initiation of treatment and preventive measures such as oral administration of anti-hypertensive drugs and abstinence from smoking.</p><p>See <a href="#carasil.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="carasil.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="carasil.Genetic_Counseling"><h2 id="_carasil_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="carasil.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>HTRA1</i> disorder caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants (classic CARASIL) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p><p><i>HTRA1</i> disorder caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (<i>HTRA1</i>-CSVD) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="carasil.Autosomal_Recessive_Inheritance"><h3>Autosomal Recessive Inheritance</h3><div id="carasil.Risk_to_Family_Members"><h4>Risk to Family Members</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an individual with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>HTRA1</i> pathogenic variants are obligate heterozygotes (i.e., presumed to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for one <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> based on family history).</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to confirm that each parent is <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and to allow reliable <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> assessment. (<i>De novo</i> variants are known to occur at a low but appreciable rate in <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> disorders [<a class="bk_pop" href="#carasil.REF.j_nsson.2017.519">J&#x000f3;nsson et al 2017</a>].)</div></li><li class="half_rhythm"><div>It is not clear whether individuals who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> associated with classic CARASIL are asymptomatic. Some reports suggest a mild <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in heterozygous individuals [<a class="bk_pop" href="#carasil.REF.mendioroz.2010.2033">Mendioroz et al 2010</a>, <a class="bk_pop" href="#carasil.REF.chen.2013.1445">Chen et al 2013</a>, <a class="bk_pop" href="#carasil.REF.bianchi.2014.898">Bianchi et al 2014</a>, <a class="bk_pop" href="#carasil.REF.uemura.2019.693">Uemura et al 2019</a>]. However, it is difficult to distinguish their symptoms from small vessel disease in the elderly; further study is necessary to clarify this issue.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>If each parent is known to be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has at conception a 25% chance of inheriting both <i>HTRA1</i> pathogenic variants and being affected, a 50% chance of inheriting one pathogenic variant and being heterozygous, and a 25% chance of inheriting neither pathogenic variant and not being at risk for <i>HTRA1</i> disorder.</div></li><li class="half_rhythm"><div>It is not clear whether carriers (heterozygotes) are asymptomatic (see <b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b>).</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants are obligate heterozygotes for one <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for one <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="carasil.Heterozygote_Detection"><h4>Heterozygote Detection</h4><p>Molecular genetic testing for at-risk family members requires prior identification of the <i>HTRA1</i> pathogenic variants in the family.</p></div></div><div id="carasil.Autosomal_Dominant_Inheritance"><h3>Autosomal Dominant Inheritance &#x02013; Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>HTRA1</i> disorder have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Because <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., a single occurrence in a family) have not been evaluated sufficiently to determine if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occurred <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, the proportion of <i>HTRA1</i> disorder caused by a <i>de novo</i> pathogenic variant is unknown. (To date, <i>de novo</i> pathogenic variants have not been reported in <i>HTRA1</i> disorder.)</div></li><li class="half_rhythm"><div>Molecular genetic testing is recommended for the parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of a proband inheriting a pathogenic variant from a parent with germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with <i>HTRA1</i> disorder may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or is known to have the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the proband, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a known <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#carasil.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, sibs are still presumed to be at increased risk for <i>HTRA1</i> disorder because of the possibility of age-related <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> parent or the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> <i>HTRA1</i> disorder has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="carasil.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#carasil.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once the <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li><li class="half_rhythm"><div>Potential consequences of such testing including (but not limited to) socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result &#x02013; as well as the capabilities and limitations of predictive testing &#x02013; should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals age &#x0003c;18 years)</b></p><ul><li class="half_rhythm"><div>For asymptomatic minors at risk for adult-onset conditions for which early treatment would have no beneficial effect on disease morbidity and mortality, predictive genetic testing is considered inappropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</div></li><li class="half_rhythm"><div>For more information, see the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.</div></li></ul><p>In a family with an established diagnosis of <i>HTRA1</i> disorder, it is appropriate to consider testing symptomatic individuals regardless of age.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of genetic status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a>, or are at risk of being affected or of being heterozygous.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="carasil.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>HTRA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> for <i>HTRA1</i> disorder are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="carasil.Resources"><h2 id="_carasil_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/cerebral-autosomal-recessive-arteriopathy-with-subcortical-infarcts-and-leukoencephalopathy" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy</a></div></li><li class="half_rhythm"><div><b>American Stroke Association</b></div><div>National Center</div><div>7272 Greenville Avenue</div><div>Dallas TX 75231</div><div><b>Phone:</b> 800-AHA-USA-1; 800-242-8721</div><div><a href="https://www.strokeassociation.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.strokeassociation.org</a></div></li></ul></div><div id="carasil.Molecular_Genetics"><h2 id="_carasil_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="carasil.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>HTRA1 Disorder: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_carasil.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_carasil.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_carasil.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_carasil.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_carasil.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_carasil.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_carasil.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/5654" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HTRA1</i></a></td><td headers="hd_b_carasil.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=5654" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">10q26<wbr style="display:inline-block"></wbr>​.13</a></td><td headers="hd_b_carasil.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q92743" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Serine protease HTRA1</a></td><td headers="hd_b_carasil.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/HTRA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HTRA1 database</a></td><td headers="hd_b_carasil.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HTRA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HTRA1</a></td><td headers="hd_b_carasil.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HTRA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HTRA1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="carasil.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="carasil.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for HTRA1 Disorder (<a href="/omim/600142,602194,616779" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK32533/table/carasil.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__carasil.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600142" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600142</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/602194" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">602194</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HTRA SERINE PEPTIDASE 1; HTRA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616779" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616779</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2</td></tr></tbody></table></div></div><div id="carasil.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b> HTRA1 belongs to the HTRA protein family, the members of which have dual roles as chaperones and serine proteases [<a class="bk_pop" href="#carasil.REF.clausen.2002.443">Clausen et al 2002</a>]. They serve as stress sensors for unfolded proteins and repress transforming growth factor-beta (TGF-&#x003b2;) family signaling [<a class="bk_pop" href="#carasil.REF.clausen.2002.443">Clausen et al 2002</a>, <a class="bk_pop" href="#carasil.REF.oka.2004.1041">Oka et al 2004</a>]. HTRA1 proteins exist as trimers, thus allowing communication between adjacent subunits to regulate protease activity [<a class="bk_pop" href="#carasil.REF.truebestein.2011.386">Truebestein et al 2011</a>].</p><p>In vitro functional expression studies with <i>HTRA1</i> known pathogenic variants showed a loss of protease activity and consequent inability to repress TGF-&#x003b2; family signaling [<a class="bk_pop" href="#carasil.REF.hara.2009.1729">Hara et al 2009</a>]. Additionally, the mutated HTRA1 proteins of some pathogenic variants show a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect by interfering with communication between adjacent subunits [<a class="bk_pop" href="#carasil.REF.nozaki.2016.1964">Nozaki et al 2016</a>, <a class="bk_pop" href="#carasil.REF.uemura.2019.693">Uemura et al 2019</a>].</p><p><b>Mechanism of disease causation.</b> Loss of function. Some pathogenic variants have a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect [<a class="bk_pop" href="#carasil.REF.hara.2009.1729">Hara et al 2009</a>, <a class="bk_pop" href="#carasil.REF.nozaki.2016.1964">Nozaki et al 2016</a>, <a class="bk_pop" href="#carasil.REF.uemura.2019.693">Uemura et al 2019</a>].</p></div></div><div id="carasil.References"><h2 id="_carasil_References_">References</h2><div id="carasil.Published_Guidelines__Consensus"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="carasil.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 10-29-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 10-29-19.</div></li></ul></div><div id="carasil.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.adibsamii.2010.630">Adib-Samii P, Brice G, Martin RJ, Markus HS. Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. <span><span class="ref-journal">Stroke. </span>2010;<span class="ref-vol">41</span>:630–4.</span> [<a href="/pubmed/20167921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20167921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.bianchi.2014.898">Bianchi S, Di Palma C, Gallus GN, Taglia I, Poggiani A, Rosini F, Rufa A, Muresanu DF, Cerase A, Dotti MT, Federico A. Two novel HTRA1 mutations in a European CARASIL patient. <span><span class="ref-journal">Neurology. </span>2014;<span class="ref-vol">82</span>:898–900.</span> [<a href="/pubmed/24500651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24500651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.bugiani.2016.1777">Bugiani M, Kevelam SH, Bakels HS, Waisfisz Q, Ceuterick-de Groote C, Niessen HW, Abbink TE, Lesnik Oberstein SA, van der Knaap MS. Cathepsin A-related arteriopathy with strokes and leukoencephalopathy (CARASAL). <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">87</span>:1777–86.</span> [<a href="/pubmed/27664989" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27664989</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.chabriat.2009.643">Chabriat H, Joutel A, Dichgans M, Tournier-Lasserve E, Bousser MG. CADASIL. <span><span class="ref-journal">Lancet Neurol. </span>2009;<span class="ref-vol">8</span>:643–53.</span> [<a href="/pubmed/19539236" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19539236</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.chen.2013.1445">Chen Y, He Z, Meng S, Li L, Yang H, Zhang X. A novel mutation of the high-temperature requirement A serine peptidase 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). <span><span class="ref-journal">J Int Med Res. </span>2013;<span class="ref-vol">41</span>:1445–55.</span> [<a href="/pubmed/23963851" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23963851</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.clausen.2002.443">Clausen T, Southan C, Ehrmann M. The HtrA family of proteases: implications for protein composition and cell fate. <span><span class="ref-journal">Mol Cell. </span>2002;<span class="ref-vol">10</span>:443–55.</span> [<a href="/pubmed/12408815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12408815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.favaretto.2019.108">Favaretto S, Margoni M, Salviati L, Pianese L, Manara R, Baracchini C. A new Italian family with HTRA1 mutation associated with autosomal-dominant variant of CARASIL: are we pointing towards a disease spectrum? <span><span class="ref-journal">J Neurol Sci. </span>2019;<span class="ref-vol">396</span>:108–11.</span> [<a href="/pubmed/30447605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30447605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.fukutake.2011.85">Fukutake T. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification. <span><span class="ref-journal">J Stroke Cerebrovasc Dis. </span>2011;<span class="ref-vol">20</span>:85–93.</span> [<a href="/pubmed/21215656" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21215656</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.fukutake.1995.69">Fukutake T, Hirayama K. Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension. <span><span class="ref-journal">Eur Neurol. </span>1995;<span class="ref-vol">35</span>:69–79.</span> [<a href="/pubmed/7796840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7796840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.hara.2009.1729">Hara K, Shiga A, Fukutake T, Nozaki H, Miyashita A, Yokoseki A, Kawata H, Koyama A, Arima K, Takahashi T, Ikeda M, Shiota H, Tamura M, Shimoe Y, Hirayama M, Arisato T, Yanagawa S, Tanaka A, Nakano I, Ikeda S, Yoshida Y, Yamamoto T, Ikeuchi T, Kuwano R, Nishizawa M, Tsuji S, Onodera O. Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. <span><span class="ref-journal">N Engl J Med. </span>2009;<span class="ref-vol">360</span>:1729–39.</span> [<a href="/pubmed/19387015" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19387015</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.ito.2018">Ito J, Nozaki H, Toyoshima Y, Abe T, Sato A, Hashidate H, Igarashi S, Onodera O, Takahashi H, Kakita A. Histopathologic features of an autopsied patient with cerebral small vessel disease and a heterozygous HTRA1 mutation. <span><span class="ref-journal">Neuropathology. </span>2018.</span> Epub ahead of print. [<a href="/pubmed/29797751" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29797751</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.ito.2016">Ito S, Takao M, Fukutake T, Hatsuta H, Funabe S, Ito N, Shimoe Y, Niki T, Nakano I, Fukayama M, Murayama S. Histopathologic analysis of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): a report of a new genetically confirmed case and comparison to 2 previous cases. <span><span class="ref-journal">J Neuropathol Exp Neurol. </span>2016.</span> Epub ahead of print. [<a href="/pubmed/27634960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27634960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.j_nsson.2017.519">J&#x000f3;nsson H, Sulem P, Kehr B, Kristmundsdottir S, Zink F, Hjartarson E, Hardarson MT, Hjorleifsson KE, Eggertsson HP, Gudjonsson SA, Ward LD, Arnadottir GA, Helgason EA, Helgason H, Gylfason A, Jonasdottir A, Jonasdottir A, Rafnar T, Frigge M, Stacey SN, Th Magnusson O, Thorsteinsdottir U, Masson G, Kong A, Halldorsson BV, Helgason A, Gudbjartsson DF, Stefansson K. Parental influence on human germline de novo mutations in 1,548 trios from Iceland. <span><span class="ref-journal">Nature. </span>2017;<span class="ref-vol">549</span>:519–22.</span> [<a href="/pubmed/28959963" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28959963</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.low.2007.357">Low WC, Junna M, Borjesson-Hanson A, Morris CM, Moss TH, Stevens DL, St Clair D, Mizuno T, Zhang WW, Mykkanen K, Wahlstrom J, Andersen O, Kalimo H, Viitanen M, Kalaria RN. Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>:357–67.</span> [<a href="/pubmed/17235124" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17235124</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.mendioroz.2010.2033">Mendioroz M, Fern&#x000e1;ndez-Cadenas I, Del R&#x000ed;o-Espinola A, Rovira A, Sol&#x000e9; E, Fern&#x000e1;ndez-Figueras MT, Garc&#x000ed;a-Patos V, Sastre-Garriga J, Domingues-Montanari S, Alvarez-Sab&#x000ed;n J, Montaner J. A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian population. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:2033–5.</span> [<a href="/pubmed/21115960" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21115960</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.nishimoto.2011.1353">Nishimoto Y, Shibata M, Nihonmatsu M, Nozaki H, Shiga A, Shirata A, Yamane K, Kosakai A, Takahashi K, Nishizawa M, Onodera O, Suzuki N. A novel mutation in the HTRA1 gene causes CARASIL without alopecia. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">76</span>:1353–5.</span> [<a href="/pubmed/21482952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21482952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.nozaki.2016.1964">Nozaki H, Kato T, Nihonmatsu M, Saito Y, Mizuta I, Noda T, Koike R, Miyazaki K, Kaito M, Ito S, Makino M, Koyama A, Shiga A, Uemura M, Sekine Y, Murakami A, Moritani S, Hara K, Yokoseki A, Kuwano R, Endo N, Momotsu T, Yoshida M, Nishizawa M, Mizuno T, Onodera O. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. <span><span class="ref-journal">Neurology. </span>2016;<span class="ref-vol">86</span>:1964–74.</span> [<a href="/pubmed/27164673" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27164673</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.nozaki.2014.3447">Nozaki H, Nishizawa M, Onodera O. Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. <span><span class="ref-journal">Stroke. </span>2014;<span class="ref-vol">45</span>:3447–53.</span> [<a href="/pubmed/25116877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25116877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.nozaki.2015.459">Nozaki H, Sekine Y, Fukutake T, Nishimoto Y, Shimoe Y, Shirata A, Yanagawa S, Hirayama M, Tamura M, Nishizawa M, Onodera O. Characteristic features and progression of abnormalities on MRI for CARASIL. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:459–63.</span> [<a href="/pubmed/26138950" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26138950</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.oide.2008.132">Oide T, Nakayama H, Yanagawa S, Ito N, Ikeda S, Arima K. Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). <span><span class="ref-journal">Neuropathology. </span>2008;<span class="ref-vol">28</span>:132–42.</span> [<a href="/pubmed/18021191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18021191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.oka.2004.1041">Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. <span><span class="ref-journal">Development. </span>2004;<span class="ref-vol">131</span>:1041–53.</span> [<a href="/pubmed/14973287" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14973287</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.okeda.2004.21">Okeda R, Murayama S, Sawabe M, Kuroiwa T. Pathology of the cerebral artery in Binswanger's disease in the aged: observation by serial sections and morphometry of the cerebral arteries. <span><span class="ref-journal">Neuropathology. </span>2004;<span class="ref-vol">24</span>:21–9.</span> [<a href="/pubmed/15068169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15068169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR, Hurles ME, et al.  Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.singhal.2004.2031">Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. <span><span class="ref-journal">Brain. </span>2004;<span class="ref-vol">127</span>:2031–8.</span> [<a href="/pubmed/15229130" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15229130</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.truebestein.2011.386">Truebestein L, Tennstaedt A, M&#x000f6;nig T, Krojer T, Canellas F, Kaiser M, Clausen T, Ehrmann M. <span><span class="ref-journal">Nat Struct Mol Biol. </span>2011;<span class="ref-vol">18</span>:386–8.</span> [<a href="/pubmed/21297635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21297635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.uemura.2019.693">Uemura M, Nozaki H, Koyama A, Sakai N, Ando S, Kanazawa M, Kato T, Onodera O. HTRA1 mutations identified in symptomatic carriers have the property of interfering the trimer-dependent activation cascade. <span><span class="ref-journal">Front Neurol. </span>2019;<span class="ref-vol">10</span>:693.</span> [<a href="/pmc/articles/PMC6611441/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6611441</span></a>] [<a href="/pubmed/31316458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 31316458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.verdura.2015.2347">Verdura E, Herv&#x000e9; D, Scharrer E, Amador Mdel M, Guyant-Mar&#x000e9;chal L, Philippi A, Corlob&#x000e9; A, Bergametti F, Gazal S, Prieto-Morin C, Beaufort N, Le Bail B, Viakhireva I, Dichgans M, Chabriat H, Haffner C, Tournier-Lasserve E. Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. <span><span class="ref-journal">Brain. </span>2015;<span class="ref-vol">138</span>:2347–58.</span> [<a href="/pubmed/26063658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26063658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.verreault.2006.353">Verreault S, Joutel A, Riant F, Neves G, Rui Silva M, Maciazek J, Tournier-Lasserve E, Bousser MG, Chabriat H. A novel hereditary small vessel disease of the brain. <span><span class="ref-journal">Ann Neurol. </span>2006;<span class="ref-vol">59</span>:353–7.</span> [<a href="/pubmed/16404745" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16404745</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="carasil.REF.yanagawa.2002.817">Yanagawa S, Ito N, Arima K, Ikeda S. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. <span><span class="ref-journal">Neurology. </span>2002;<span class="ref-vol">58</span>:817–20.</span> [<a href="/pubmed/11889251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11889251</span></a>]</div></li></ul></div></div><div id="carasil.Chapter_Notes"><h2 id="_carasil_Chapter_Notes_">Chapter Notes</h2><div id="carasil.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>7 November 2019 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 September 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 February 2011 (cd) Revision: prenatal testing available clinically</div></li><li class="half_rhythm"><div>27 April 2010 (me) Review posted live</div></li><li class="half_rhythm"><div>5 January 2010 (oo) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK32533</span><span class="label">PMID: <a href="/pubmed/20437615" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20437615</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hemochromatosis/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hfg/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK32533&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK32533/?report=reader">PubReader</a></li><li><a href="/books/NBK32533/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK32533" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK32533" style="display:none" title="Cite this Page"><div class="bk_tt">Onodera O, Nozaki H, Fukutake T. HTRA1 Disorder. 2010 Apr 27 [Updated 2019 Nov 7]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK32533/pdf/Bookshelf_NBK32533.pdf">PDF version of this page</a> (472K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#carasil.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#carasil.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#carasil.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#carasil.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#carasil.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#carasil.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#carasil.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#carasil.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#carasil.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#carasil.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#carasil.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#carasil.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=5654[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HTRA1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK32533+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1990796" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1990796" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1990796" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1990796" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21215656" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification.</a><span class="source">[J Stroke Cerebrovasc Dis. 2011]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Fukutake T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Stroke Cerebrovasc Dis. 2011 Mar-Apr; 20(2):85-93. Epub 2011 Jan 7.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28126975" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">[Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)].</a><span class="source">[Brain Nerve. 2017]</span><div class="brieflinkpop offscreen_noflow">[Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)].<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Uemura M, Nozaki H, Onodera O. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Brain Nerve. 2017 Jan; 69(1):25-33. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301707" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Megalencephalic Leukoencephalopathy with Subcortical Cysts</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Megalencephalic Leukoencephalopathy with Subcortical Cysts<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van der Knaap MS, Abbink TEM, Min R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301673" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CADASIL</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CADASIL<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hack R, Rutten J, Lesnik Oberstein SAJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20437615" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20437615" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04130239a66ee2bac1e339">HTRA1 Disorder - GeneReviews®</a><div class="ralinkpop offscreen_noflow">HTRA1 Disorder - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:55:14-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE881C4CE0411951000000000096003C&amp;ncbi_session=CE881C4CE0413011_0150SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK32533%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK32533&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK32533/&amp;ncbi_pagename=HTRA1 Disorder - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE881C4CE0413011_0150SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>